Financial Health Assessment: THE LEARN CENTRE LIMITED

1. Financial Health Score: B+

Explanation: The patient exhibits a robust underlying constitution, characterized by a strong balance sheet, excellent liquidity, and years of steady asset growth. However, the recent shift from profit to a significant loss in FY2025, combined with a draining cash reserve and a recent change in corporate "DNA" (the acquisition by Bright SG Limited), prevents a perfect score. The company is healthy but is currently in a post-operative recovery phase following a major corporate transplant.

2. Key Vital Signs

• Net Assets (The Patient's Constitution): £897,236 (2024). The company has built a strong foundation, growing its net assets from £306,385 in 2019 to nearly £900k in 2024. This indicates a historically robust ability to retain wealth and weather economic storms.
• Cash Position (Blood Pressure & Circulation): £631,339 (2024). While still exceptionally healthy relative to total liabilities (£413,211), cash levels have been steadily declining from a peak of £950,264 in 2021. The patient is bleeding cash, though current circulation remains more than adequate to keep the organs functioning.
• Total Liabilities (Cholesterol Levels): £413,211 (2024). Liabilities have remained relatively stable and are well-covered by cash alone. There are no signs of clogged arteries or dangerous debt burdens.
• Profitability (Metabolism): FY2025 saw a loss of £271,708, a sharp contrast to the £75,588 profit generated in FY2024. The patient's metabolism has suddenly shifted from burning energy efficiently to running at a deficit.
• Corporate Governance (The Nervous System): Complete overhaul. The acquisition by Bright SG Limited on July 31, 2025, resulted in the resignation of the previous board of directors and the appointment of new leadership (Xxxxxx Xxxxxxxxname shown to subscribers, Xxxxxx Xxxxxxxxname shown to subscribers, and Xxxxxx Xxxxxxxxname shown to subscribers). The nervous system has been completely rewired.

3. Diagnosis

Symptoms Analysis: The Corporate Transplant

The financial data reveals a business that was historically healthy but has recently undergone a significant physiological shock. From 2019 to 2024, the company enjoyed steady growth in net assets, acting as a strong, reliable "organism" in the UK payroll education sector.

However, the FY2025 accounts reveal two concerning symptoms: 1. The Hemorrhage (Loss of £271,708): After years of profitability, the sudden shift to a heavy loss suggests an acute event rather than a chronic operational disease. Given the timing, this loss is highly likely a "surgical scar"—a combination of one-off acquisition costs, restructuring expenses, or asset write-downs associated with the change in ownership. 2. The Cash Drain: Cash has dropped by roughly £319,000 over the last three years (from £950k to £631k) while net assets continued to rise until 2024. This historical cash drain, combined with the sudden FY2025 loss, suggests the previous owners may have been extracting value from the business (via dividends) in the years leading up to the sale, leaving slightly less financial padding for the new owners.

Overall Diagnosis: The company is suffering from acute post-acquisition trauma. The underlying business (education/training) is fundamentally sound with no structural debt issues, but the recent change in ownership has temporarily shocked the system, resulting in a significant loss for the 2025 financial year. The previous management extracted value before handover, and the new management is now stabilizing the patient.

4. Recommendations

To restore the patient to peak physical condition and ensure a successful recovery under the new parent company (Bright SG Limited), the following interventions are recommended:

• Post-Operative Monitoring of the FY2025 Loss: The new directors must isolate the root cause of the £271k loss. If it is purely accounting adjustments or one-off transaction costs from the acquisition, no further treatment is needed. However, if the loss reflects a fundamental decline in the core training revenue, immediate operational adjustments are required.
• Stop the Cash Bleeding: While liquidity is currently strong, the downward trend in cash reserves must be stabilized. Implement strict cash flow management and working capital controls until the business is consistently generating positive cash flow under the new regime.
• Strategic Rehabilitation: With the new directors (Xxxxxxxname shown to subscribers, Xxxxxxxname shown to subscribers, and Brown) at the helm, a fresh strategic plan is required. The new leadership must ensure that the company's "muscle memory" (its expertise in payroll training) is retained and integrated effectively with the broader goals of Bright SG Limited.
• Maintain Debt Discipline: With total liabilities well-covered by cash, the company must avoid taking on unnecessary financial "weight." Preserve the current low-leverage position to maintain flexibility as the new corporate structure beds in.

Names of the people mentioned are shown to subscribers. See subscription